Trial watch: novel antiarrhythmic agent shows promise in Phase III trial (Q83592785)

scientific article published on 01 April 2009

Language	Label	Description	Also known as
English	Trial watch: novel antiarrhythmic agent shows promise in Phase III trial	scientific article published on 01 April 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

title

Trial watch: novel antiarrhythmic agent shows promise in Phase III trial (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

main subject

phase III clinical trial

1 reference

based on heuristic

inferred from title

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

published in

Nature Reviews Drug Discovery

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

volume

8

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

page(s)

266

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

retrieved

25 January 2020

exact match

https://scigraph.springernature.com/pub.10.1038/nrd2860

0 references

cites work

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2860

retrieved

31 March 2020

Innovative approaches to anti-arrhythmic drug therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRD2860

retrieved

31 March 2020

Identifiers

DOI

10.1038/NRD2860

1 reference

stated in

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

PubMed ID

19337265

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19337265%20AND%20SRC:MED&resulttype=core&format=json

Trial watch: novel antiarrhythmic agent shows promise in Phase III trial (Q83592785)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Trial watch: novel antiarrhythmic agent shows promise in Phase III trial (Q83592785)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search